QuantHealth raises $45 million to run AI simulations of clinical trials
QuantHealth has raised $45 million in a Series B round. Its AI simulations let drugmakers test and adjust trial designs before enrolling patients.
Who is affected and how
- pharmaceuticals
- In the trial-design phase, simulation tools can screen out designs prone to failure before patients are enrolled.
Sources
- QuantHealth raises $45M series B to accelerate AI-driven clinical trial simulationsfierce healthcare · Aug 4, 2026
- QuantHealth raises $45 million Series B to bring AI simulations to the costly world of clinical trialsctech · Aug 4, 2026
- QuantHealth raises $45 million Series B to bring AI simulations to the costly world o | Ctechcalcalistech.com · Aug 4, 2026
- QuantHealth banks $45M for AI clinical trial simulationsfiercehealthcare.com · Aug 4, 2026
- Exclusive: QuantHealth raises $45M to simulate clinical trials - Axiosaxios.com · Aug 4, 2026 · magyar
- QuantHealth lands $45M for AI clinical trial simulationsmobihealthnews · Aug 5, 2026
- QuantHealth lands $45M for AI clinical trial simulations - MobiHealthNewsmobihealthnews.com · Aug 5, 2026 · magyar
- Can AI fix broken clinical trials? This platform wants to predict failures before they happen - ynetnews.comynetnews.com · Aug 4, 2026 · magyar
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.